First-line treatment of metastatic breast cancer: current strategies and emerging systemic therapies
A Brufsky - Community Oncology, 2010 - infona.pl
Prognosis is poor after a diagnosis of metastatic breast cancer (MBC), with a median
survival of 2-4 years. Individualized treatment is aimed at stabilizing disease without …
survival of 2-4 years. Individualized treatment is aimed at stabilizing disease without …